Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,282.50
Bid: 1,285.00
Ask: 1,285.50
Change: -9.50 (-0.74%)
Spread: 0.50 (0.039%)
Open: 1,291.50
High: 1,323.00
Low: 1,274.00
Prev. Close: 1,292.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jan 2019 07:00

RNS Number : 0612N
Persimmon PLC
15 January 2019
 

TRADING UPDATE - 15 JANUARY 2019

 

Persimmon plc announces the following update ahead of its Final Results for the year ended 31 December 2018, which will be released on 26 February 2019.

 

Persimmon has delivered another strong trading performance, with continued disciplined growth in 2018 in line with the Group's strategy. Total Group revenues of £3.74bn were 4% higher than the prior year (2017: £3.60bn). New housing revenues increased by 4% to £3.55bn (2017: £3.42bn). Legal completion volumes increased by 406 new homes, a 3% increase, to 16,449 (2017: 16,043), including private sales of 13,341 new homes (2017: 13,274). Our average selling price of c. £215,560 was 1% higher than last year (2017: £213,321). The UK housing market has continued to benefit from robust employment levels, low interest rates and a competitive mortgage market, which have supported confidence and customer demand across the regions.

 

Persimmon remains committed to increasing new home construction to meet market demand and has made a significant contribution to increasing UK housing supply since the launch of the Group's new strategy in 2012. Over this period we have opened 1,370 new selling outlets and delivered 97,175 new homes to the market, increasing our annual production by over 75%. The Group now has 31 house building businesses across the UK, having opened seven new businesses over the last four years. The Group opened a new operating business based near Ipswich in Suffolk on 2 January 2018 which has made good progress, delivering 348 new homes in 2018. Additionally, on 2 January 2019, we opened a new business based at Harworth, near Doncaster, which will support our growth across the Yorkshire region. The Group is seeking to identify similar regional expansion opportunities and will continue to invest in both its infrastructure and people to support further growth.

 

The Group has a strong platform as we move into the new year. The value of the Group's forward sales at 31 December 2018 of c. £1,395m was 3% ahead of the prior year (2017: £1,356m) after second half legal completion volumes of 8,377, which were 305 stronger than for the first half of the year (H1: 8,072), an increase of 4%. The Group is currently building new homes on c. 365 active developments, a similar number to the same point last year, offering a good range and choice of family homes for first time buyers and home movers. We will be adding to our outlet network with the launch of a variety of high quality new sites over the coming weeks and are looking forward to the new spring season with a robust development pipeline. The c. 55 sites that we plan to open through the first quarter of the year include 15 outlets where we have been progressing build programmes to a more advanced stage to support improved availability and moving in dates for our customers.

We have continued with a selective approach to land replacement in line with our strategic priorities, being mindful of market cycle risks and wider economic uncertainties, including those associated with the process of the UK leaving the EU. The Group acquired over 17,000 plots of new land in over 80 locations through the year, with anticipated margins which continue to meet our targets.

 

The Group's cash generation remains strong. Cash balances of c. £1,048m were held at 31 December 2018 (2017: £1,303m) after returning £732m of capital to shareholders in 2018 (2017: £417m).

 

We anticipate our pre-tax profits for 2018 will be modestly ahead of current market consensus, having benefitted from the new developments we have opened through the year.

 

The Group continues to develop its manufacturing capabilities with the aim of better supporting sustainable growth. Brickworks, our new brick manufacturing plant located at Harworth, near Doncaster, is now nearing optimal production levels. The construction of the Group's new roof tile manufacturing plant, Tileworks, is progressing well on the same site. We look forward to Tileworks commencing deliveries to the business in the second half of 2019. In addition, Space4, the Group's manufacturing facility for our insulated frame build-system, based near Birmingham, continues to make a valuable contribution to the Group's output.

 

As we look forward to the 2019 spring season Persimmon is in an excellent market position. Whilst the future performance of the UK economy is currently subject to increased levels of uncertainty the Group is well positioned with its strong outlet network together with the availability of a range of attractive house types at affordable prices across the regions of the UK, supported by a high quality land bank and conservative financial structure. We will give an update on our assessment of the housing market over the early weeks of 2019 when we announce our results for the year ended 31 December 2018 on Tuesday 26 February 2019.

 

 

Please Note

There will be a call for analysts at 09.00 GMT today. Please use the dial-in details below:

Telephone number

:

+44 (0)33 3300 0804

Access pin

:

47240467#

Passcode

:

Persimmon

 

An audiocast of the call will be available on www.persimmonhomes.com/corporate

 

For further information please contact:

 

Dave Jenkinson, Interim Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Jos Bieneman

Persimmon plc

Citigate Dewe Rogerson

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGMGMMNDLGLZM
Date   Source Headline
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.